Proactive Investors - Run By Investors For Investors

LeanLife hits new milestone, ships first Omega-3 product samples

The Vancouver-based company developed a patented process to isolate Omega-3 fatty acids from flax seeds that can be used as food additives or nutraceuticals
omega-3
LeanLife shipped samples of its Omega-3 products to a potential consumer base in Europe

LeanLife Health Inc (CSE:LLP) has shipped its first Omega-3 product samples to potential customers in Europe, the company announced Thursday.

Shares jumped around 33% on Thursday morning to reach C$0.06 in Canada.

The Vancouver-based company develops proprietary plant-based food products that can be used as food additives or nutraceuticals. It has a patented process to isolate Omega-3 fatty acids from flax seeds.

LeanLife’s proprietary Omega-3 product was shipped to Europe, where it will be distributed to a consumer base of some of the continent’s largest producers of bread, pasta, cheese, yogurt and butter.

READ: LeanLife testing exceeds expectations, gears up for commercialization of Omega-3 fatty acids

Recently, a trial application using the Omega-3 product as a substitute for vegetable oil showed negligible difference in taste and quality, LeanLife said in a statement.

The testing resulted in the production of samples which will now be evaluated by a third-party accredited lab.

According to the extract manufacturer, the company is ready to begin large-scale production and fulfill multiple orders following the validation of samples by buyers.

CEO Stan Lis said that LeanLife is “very excited” to be back in production. “Now that LeanLife is capable of producing in large volumes, the shipping of samples to potential customers that have been waiting for our product brings the company to the verge of revenue generation in this multi-billion dollar market,” he said in a statement.

“Our salesforce in Europe has been eagerly awaiting the opportunity to revisit potential customers. As the awareness of the importance of healthy eating continues to expand, LeanLife intends to meet the growing consumer demand for plant-based essential food ingredients.”

The global Omega-3 market reached US$33 billion in 2016 and is expected to reach nearly US$57 billion by 2025, according to data provided by LeanLife.

--Updates with share price--

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

1550834286_shutterstock_651647128.jpg
February 22 2019
The company is developing drugs for blood disorders, metabolic diseases and curbing alcohol use
man with erectile dysfunction
June 17 2019
Headline results from the trial of MED2005 are due before the end of 2019, while Futura is also confident of hearing back from UK regulators about its pain relief gel later in the year
1550762209_shutterstock_291998651.jpg
February 21 2019
Motif’s lead drug candidate is iclaprim, a next-generation antibiotic for which it was seeking US FDA approval for use in patients with acute bacterial skin and skin structure infections
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use